{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:49:17Z","timestamp":1789494557772,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFC2703401"],"award-info":[{"award-number":["2022YFC2703401"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Newborn screening (NBS) for severe combined immunodeficiency (SCID), X-linked agammaglobulinemia (XLA), and spinal muscular atrophy (SMA) enables early diagnosis and intervention, significantly improving patient outcomes. Advances in real-time polymerase chain reaction (PCR) technology have been instrumental in facilitating their inclusion in NBS programs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We employed multiplex real-time PCR to simultaneously detect T-cell receptor excision circles (TRECs), kappa-deleting recombination excision circles (KRECs), and the absence of the survival motor neuron (\n                      <jats:italic>SMN<\/jats:italic>\n                      ) 1 gene in dried blood spots from 103,240 newborns in Zhejiang Province, China, between July 2021 and December 2022.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of all the samples, 122 were requested further evaluation. After flow cytometry evaluation and\/or genetic diagnostics, we identified one patient with SCID, two patients with XLA, nine patients with SMA [one of whom also had Wiskott\u2013Aldrich Syndrome (WAS)], and eight patients with other medical conditions. The positive predictive values (PPVs) of NBS for SCID, XLA, and SMA were 2.44%, 2.78%, and 100%, respectively. The estimated prevalence rates in the Chinese population were 1 in 103,240 for SCID, 1 in 51,620 for XLA, and 1 in 11,471 for SMA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study represents the first large-scale screening in mainland China using a TREC\/KREC\/SMN1 multiplex assay, providing valuable epidemiological data. Our findings suggest that this multiplex assay is an effective screening method for SCID, XLA, and SMA, potentially supporting the universal implementation of NBS programs across China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s12519-024-00846-7","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T14:03:00Z","timestamp":1730815380000},"page":"1270-1282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Comprehensive newborn screening for severe combined immunodeficiency, X-linked agammaglobulinemia, and spinal muscular atrophy: the Chinese experience"],"prefix":"10.1007","volume":"20","author":[{"given":"Chi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1464-2226","authenticated-orcid":false,"given":"Ru-Lai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"846_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jaci.2020.10.020","volume":"147","author":"R Currier","year":"2021","unstructured":"Currier R, Puck JM. SCID newborn screening: what we\u2019ve learned. J Allergy Clin Immunol. 2021;147:417\u201326.","journal-title":"J Allergy Clin Immunol"},{"key":"846_CR2","first-page":"107","volume":"37","author":"X Gu","year":"2008","unstructured":"Gu X, Wang Z, Ye J, Han L, Qiu W. Newborn screening in China: phenylketonuria, congenital hypothyroidism and expanded screening. Ann Acad Med Singap. 2008;37:107\u201314.","journal-title":"Ann Acad Med Singap"},{"key":"846_CR3","doi-asserted-by":"publisher","first-page":"E1551","DOI":"10.1503\/cmaj.170561","volume":"189","author":"CM Biggs","year":"2017","unstructured":"Biggs CM, Haddad E, Issekutz TB, Roifman CM, Turvey SE. Newborn screening for severe combined immunodeficiency: a primer for clinicians. CMAJ. 2017;189:E1551\u20137.","journal-title":"CMAJ"},{"key":"846_CR4","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1182\/blood.V99.9.3449","volume":"99","author":"MD Hazenberg","year":"2002","unstructured":"Hazenberg MD, Otto SA, de Pauw ES, Roelofs H, Fibbe WE, Hamann D, et al. T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events. Blood. 2002;99:3449\u201353.","journal-title":"Blood"},{"key":"846_CR5","doi-asserted-by":"publisher","first-page":"15071","DOI":"10.1038\/nrdp.2015.71","volume":"1","author":"DM McDonald-McGinn","year":"2015","unstructured":"McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JA, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers. 2015;1:15071.","journal-title":"Nat Rev Dis Primers."},{"key":"846_CR6","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s10875-013-9917-y","volume":"33","author":"CC Dvorak","year":"2013","unstructured":"Dvorak CC, Cowan MJ, Logan BR, Notarangelo LD, Griffith LM, Puck JM, et al. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. J Clin Immunol. 2013;33:1156\u201364.","journal-title":"J Clin Immunol"},{"key":"846_CR7","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1401177","volume":"371","author":"SY Pai","year":"2014","unstructured":"Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency, 2000\u20132009. N Engl J Med. 2014;371:434\u201346.","journal-title":"N Engl J Med"},{"key":"846_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1084\/jem.20060964","volume":"204","author":"MC van Zelm","year":"2007","unstructured":"van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJ. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med. 2007;204:645\u201355.","journal-title":"J Exp Med"},{"key":"846_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jaci.2011.01.052","volume":"128","author":"N Nakagawa","year":"2011","unstructured":"Nakagawa N, Imai K, Kanegane H, Sato H, Yamada M, Kondoh K, et al. Quantification of \u03ba-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects. J Allergy Clin Immunol. 2011;128:223-5.e2.","journal-title":"J Allergy Clin Immunol"},{"key":"846_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/ijns3020011","volume":"3","author":"RH Zetterstr\u00f6m","year":"2017","unstructured":"Zetterstr\u00f6m RH, Barbaro M, Ohlsson A, Borte S, Jonsson S, Winiarski J, et al. Newborn screening for primary immune deficiencies with a TREC\/KREC\/ACTB triplex assay\u2014a three-year pilot study in Sweden. Int J Neonat Screen. 2017;3:11.","journal-title":"Int J Neonat Screen"},{"key":"846_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/pai.12501","volume":"27","author":"B de Felipe","year":"2016","unstructured":"de Felipe B, Olbrich P, Lucenas JM, Delgado-Pecellin C, Pavon-Delgado A, Marquez J, et al. Prospective neonatal screening for severe T- and B-lymphocyte deficiencies in Seville. Pediatr Allergy Immunol. 2016;27:70\u20137.","journal-title":"Pediatr Allergy Immunol"},{"key":"846_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/genes15030314","volume":"15","author":"T Kimizu","year":"2024","unstructured":"Kimizu T, Nozaki M, Okada Y, Sawada A, Morisaki M, Fujita H, et al. Multiplex real-time PCR-based newborn screening for severe primary immunodeficiency and spinal muscular Atrophy in Osaka, Japan: Our Results after 3 Years. Genes (Basel). 2024;15:314.","journal-title":"Genes (Basel)"},{"key":"846_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-018-0779-z","volume":"17","author":"S Pal Singh","year":"2018","unstructured":"Pal Singh S, Dammeijer F, Hendriks RW. Role of Bruton\u2019s tyrosine kinase in B cells and malignancies. Mol Cancer. 2018;17:57.","journal-title":"Mol Cancer"},{"key":"846_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10875-017-0455-x","volume":"38","author":"JR King","year":"2018","unstructured":"King JR, Hammarstr\u00f6m L. Newborn screening for primary immunodeficiency diseases: history, current and future practice. J Clin Immunol. 2018;38:56\u201366.","journal-title":"J Clin Immunol"},{"key":"846_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","volume":"8","author":"E Mercuri","year":"2022","unstructured":"Mercuri E, Sumner CJ, Muntoni F, Darras BT, Finkel RS. Spinal muscular atrophy. Nat Rev Dis Primers. 2022;8:52.","journal-title":"Nat Rev Dis Primers"},{"key":"846_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/TACG.S239603","volume":"14","author":"MC Keinath","year":"2021","unstructured":"Keinath MC, Prior DE, Prior TW. Spinal muscular atrophy: mutations, testing, and clinical relevance. Appl Clin Genet. 2021;14:11\u201325.","journal-title":"Appl Clin Genet"},{"key":"846_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155\u201365.","journal-title":"Cell"},{"key":"846_CR18","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/s41591-022-01867-3","volume":"28","author":"KA Strauss","year":"2022","unstructured":"Strauss KA, Farrar MA, Muntoni F, Saito K, Mendell JR, Servais L, et al. Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial. Nat Med. 2022;28:1390\u20137.","journal-title":"Nat Med"},{"key":"846_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nn.4508","volume":"20","author":"DR Corey","year":"2017","unstructured":"Corey DR. Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy. Nat Neurosci. 2017;20:497\u20139.","journal-title":"Nat Neurosci"},{"key":"846_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s40263-022-00910-8","volume":"36","author":"J Paik","year":"2022","unstructured":"Paik J. Risdiplam: a review in spinal muscular atrophy. CNS Drugs. 2022;36:401\u201310.","journal-title":"CNS Drugs"},{"key":"846_CR21","unstructured":"Health Resources & Services Administration (HRSA). Recommended uniform screening panel. In: Advisory Committee on Heritable Disorders in Newborns and Children. 2024. https:\/\/www.hrsa.gov\/advisory-committees\/ heritable-disorders\/rusp. Accessed 10 Jan 2024."},{"key":"846_CR22","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1212\/01.wnl.0000252934.70676.ab","volume":"68","author":"LR Simard","year":"2007","unstructured":"Simard LR, B\u00e9langer MC, Morissette S, Wride M, Prior TW, Swoboda KJ. Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with SMA. Neurology. 2007;68:451\u20136.","journal-title":"Neurology"},{"key":"846_CR23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1373\/clinchem.2014.231019","volume":"61","author":"JL Taylor","year":"2015","unstructured":"Taylor JL, Lee FK, Yazdanpanah GK, Staropoli JF, Liu M, Carulli JP, et al. Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency. Clin Chem. 2015;61:412\u20139.","journal-title":"Clin Chem"},{"key":"846_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/ijns5040039","volume":"5","author":"C Gutierrez-Mateo","year":"2019","unstructured":"Gutierrez-Mateo C, Timonen A, Vaahtera K, Jaakkola M, Hougaard DM, Bybjerg-Grauholm J, et al. Development of a multiplex real-time PCR assay for the newborn screening of SCID, SMA, and XLA. Int J Neonat Screen. 2019;5:39.","journal-title":"Int J Neonat Screen"},{"key":"846_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/bdr2.1653","volume":"112","author":"SE McCandless","year":"2020","unstructured":"McCandless SE, Wright EJ. Mandatory newborn screening in the United States: history, current status, and existential challenges. Birth Defects Res. 2020;112:350\u201366.","journal-title":"Birth Defects Res"},{"key":"846_CR26","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.3389\/fimmu.2017.01448","volume":"8","author":"E Rechavi","year":"2017","unstructured":"Rechavi E, Lev A, Simon AJ, Stauber T, Daas S, Saraf-Levy T, et al. First year of Israeli newborn screening for severe combined immunodeficiency-clinical achievements and insights. Front Immunol. 2017;8:1448.","journal-title":"Front Immunol"},{"key":"846_CR27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10875-011-9609-4","volume":"32","author":"JW Verbsky","year":"2012","unstructured":"Verbsky JW, Baker MW, Grossman WJ, Hintermeyer M, Dasu T, Bonacci B, et al. Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008\u20132011). J Clin Immunol. 2012;32:82\u20138.","journal-title":"J Clin Immunol"},{"key":"846_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/ijns3030016","volume":"3","author":"Y-H Chien","year":"2017","unstructured":"Chien Y-H, Yu H-H, Lee N-C, Ho H-C, Kao S-M, Lu M-Y, et al. Newborn screening for severe combined immunodeficiency in Taiwan. Int J Neonat Screen. 2017;3:16.","journal-title":"Int J Neonat Screen"},{"key":"846_CR29","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/BF00916954","volume":"8","author":"O Ryser","year":"1988","unstructured":"Ryser O, Morell A, Hitzig WH. Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. J Clin Immunol. 1988;8:479\u201385.","journal-title":"J Clin Immunol"},{"key":"846_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1023\/A:1027382916924","volume":"17","author":"N Matamoros Flor\u00ed","year":"1997","unstructured":"Matamoros Flor\u00ed N, Mila Llambi J, Espa\u00f1ol Boren T, Raga Borja S, Fontan CG. Primary immunodeficiency syndrome in Spain: first report of the National Registry in Children and Adults. J Clin Immunol. 1997;17:333\u20139.","journal-title":"J Clin Immunol"},{"key":"846_CR31","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1023\/A:1026416017763","volume":"20","author":"A Stray-Pedersen","year":"2000","unstructured":"Stray-Pedersen A, Abrahamsen TG, Fr\u00f8land SS. Primary immunodeficiency diseases in Norway. J Clin Immunol. 2000;20:477\u201385.","journal-title":"J Clin Immunol"},{"key":"846_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10875-017-0378-6","volume":"37","author":"A Broides","year":"2017","unstructured":"Broides A, Nahum A, Mandola AB, Rozner L, Pinsk V, Ling G, et al. Incidence of typically severe primary immunodeficiency diseases in consanguineous and non-consanguineous populations. J Clin Immunol. 2017;37:295\u2013300.","journal-title":"J Clin Immunol"},{"key":"846_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","volume":"85","author":"JA Winkelstein","year":"2006","unstructured":"Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore). 2006;85:193\u2013202.","journal-title":"Medicine (Baltimore)"},{"key":"846_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41436-019-0673-0","volume":"22","author":"DST Kariyawasam","year":"2020","unstructured":"Kariyawasam DST, Russell JS, Wiley V, Alexander IE, Farrar MA. The implementation of newborn screening for spinal muscular atrophy: the Australian experience. Genet Med. 2020;22:557\u201365.","journal-title":"Genet Med"},{"key":"846_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jpeds.2017.06.042","volume":"190","author":"YH Chien","year":"2017","unstructured":"Chien YH, Chiang SC, Weng WC, Lee NC, Lin CJ, Hsieh WS, et al. Presymptomatic diagnosis of spinal muscular atrophy through newborn screening. J Pediatr. 2017;190:124-9.e1.","journal-title":"J Pediatr"},{"key":"846_CR36","doi-asserted-by":"publisher","first-page":"e1527","DOI":"10.1212\/WNL.0000000000200986","volume":"99","author":"BH Lee","year":"2022","unstructured":"Lee BH, Deng S, Chiriboga CA, Kay DM, Irumudomon O, Laureta E, et al. Newborn screening for spinal muscular atrophy in New York state: clinical outcomes from the first 3 years. Neurology. 2022;99:e1527\u201337.","journal-title":"Neurology"},{"key":"846_CR37","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3389\/fgene.2019.01255","volume":"10","author":"Y Lin","year":"2019","unstructured":"Lin Y, Lin CH, Yin X, Zhu L, Yang J, Shen Y, et al. Newborn screening for spinal muscular atrophy in China using DNA mass spectrometry. Front Genet. 2019;10:1255.","journal-title":"Front Genet"},{"key":"846_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10875-014-0006-7","volume":"34","author":"BH Vogel","year":"2014","unstructured":"Vogel BH, Bonagura V, Weinberg GA, Ballow M, Isabelle J, DiAntonio L, et al. Newborn screening for SCID in New York State: experience from the first two years. J Clin Immunol. 2014;34:289\u2013303.","journal-title":"J Clin Immunol"},{"key":"846_CR39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.clim.2013.11.012","volume":"150","author":"M Audrain","year":"2014","unstructured":"Audrain M, Thomas C, Mirallie S, Bourgeois N, Sebille V, Rabetrano H, et al. Evaluation of the T-cell receptor excision circle assay performances for severe combined immunodeficiency neonatal screening on Guthrie cards in a French single centre study. Clin Immunol. 2014;150:137\u20139.","journal-title":"Clin Immunol"},{"key":"846_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fnins.2013.00079","volume":"7","author":"JM Melville","year":"2013","unstructured":"Melville JM, Moss TJ. The immune consequences of preterm birth. Front Neurosci. 2013;7:79.","journal-title":"Front Neurosci"},{"key":"846_CR41","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s11886-020-01405-y","volume":"22","author":"B Kelly","year":"2020","unstructured":"Kelly B, Mohanakumar S, Hjortdal VE. Diagnosis and management of lymphatic disorders in congenital heart disease. Curr Cardiol Rep. 2020;22:164.","journal-title":"Curr Cardiol Rep"},{"key":"846_CR42","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/jcu.22419","volume":"45","author":"C Tangshewinsirikul","year":"2017","unstructured":"Tangshewinsirikul C, Panburana P. Sonographic measurement of fetal thymus size in uncomplicated singleton pregnancies. J Clin Ultrasound. 2017;45:150\u20139.","journal-title":"J Clin Ultrasound"},{"key":"846_CR43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000153099","volume":"95","author":"L Duijts","year":"2009","unstructured":"Duijts L, Bakker-Jonges LE, Labout JA, Jaddoe VW, Hofman A, Steegers EA, et al. Fetal growth influences lymphocyte subset counts at birth: the generation R Study. Neonatology. 2009;95:149\u201356.","journal-title":"Neonatology"},{"key":"846_CR44","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00404-010-1375-7","volume":"283","author":"K Srisupundit","year":"2011","unstructured":"Srisupundit K, Piyamongkol W, Tongprasert F, Luewan S, Tongsong T. Reference range of fetal splenic circumference from 14 to 40 weeks of gestation. Arch Gynecol Obstet. 2011;283:449\u201353.","journal-title":"Arch Gynecol Obstet"},{"key":"846_CR45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/j.semperi.2015.03.004","volume":"39","author":"A Kwan","year":"2015","unstructured":"Kwan A, Puck JM. History and current status of newborn screening for severe combined immunodeficiency. Semin Perinatol. 2015;39:194\u2013205.","journal-title":"Semin Perinatol"},{"key":"846_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114514","volume":"9","author":"E Fro\u0148kov\u00e1","year":"2014","unstructured":"Fro\u0148kov\u00e1 E, Klocperk A, Svato\u0148 M, Nov\u00e1kov\u00e1 M, Kotrov\u00e1 M, Kayserov\u00e1 J, et al. The TREC\/KREC assay for the diagnosis and monitoring of patients with DiGeorge syndrome. PLoS ONE. 2014;9:e114514.","journal-title":"PLoS ONE"},{"key":"846_CR47","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/archdischild-2021-322858","volume":"107","author":"M Zenker","year":"2022","unstructured":"Zenker M, Edouard T, Blair JC, Cappa M. Noonan syndrome: improving recognition and diagnosis. Arch Dis Child. 2022;107:1073\u20138.","journal-title":"Arch Dis Child"},{"key":"846_CR48","doi-asserted-by":"publisher","first-page":"15445","DOI":"10.1038\/s41598-023-42370-0","volume":"13","author":"E Eissa","year":"2023","unstructured":"Eissa E, Afifi HH, Abo-Shanab AM, Thomas MM, Taher MB, Kandil R, et al. Importance of TREC and KREC as molecular markers for immunological evaluation of down syndrome children. Sci Rep. 2023;13:15445.","journal-title":"Sci Rep"},{"key":"846_CR49","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5114\/ceji.2022.124080","volume":"47","author":"Y Gul","year":"2022","unstructured":"Gul Y, Kapakl\u0131 H, Aytekin SE, Guner \u015eN, Keles S, Zamani AG, et al. Evaluation of immunological abnormalities in patients with rare syndromes. Cent Eur J Immunol. 2022;47:299\u2013307.","journal-title":"Cent Eur J Immunol"},{"key":"846_CR50","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.nmd.2021.03.007","volume":"31","author":"T Dangouloff","year":"2021","unstructured":"Dangouloff T, Vr\u0161\u010daj E, Servais L, Osredkar D. SMA NBS World Study Group. Newborn screening programs for spinal muscular atrophy worldwide: where we stand and where to go. Neuromuscul Disord. 2021;31:574\u201382.","journal-title":"Neuromuscul Disord"},{"key":"846_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/ijns8030045","volume":"8","author":"STF Shih","year":"2022","unstructured":"Shih STF, Keller E, Wiley V, Farrar MA, Wong M, Chambers GM. Modelling the cost-effectiveness and budget impact of a newborn screening program for spinal muscular atrophy and severe combined immunodeficiency. Int J Neonat Screen. 2022;8:45.","journal-title":"Int J Neonat Screen"},{"key":"846_CR52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/ijns5030028","volume":"5","author":"A Bessey","year":"2019","unstructured":"Bessey A, Chilcott J, Leaviss J, de la Cruz C, Wong R. A cost-effectiveness analysis of newborn screening for severe combined immunodeficiency in the UK. Int J Neonat Screen. 2019;5:28.","journal-title":"Int J Neonat Screen"},{"key":"846_CR53","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/ijns8030044","volume":"8","author":"STF Shih","year":"2022","unstructured":"Shih STF, Keller E, Wiley V, Wong M, Farrar MA, Chambers GM. Economic evaluation of newborn screening for severe combined immunodeficiency. Int J Neonat Screen. 2022;8:44.","journal-title":"Int J Neonat Screen"},{"key":"846_CR54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jpeds.2016.01.029","volume":"172","author":"Y Ding","year":"2016","unstructured":"Ding Y, Thompson JD, Kobrynski L, Ojodu J, Zarbalian G, Grosse SD. Cost-effectiveness\/cost-benefit analysis of newborn screening for severe combined immune deficiency in Washington State. J Pediatr. 2016;172:127\u201335.","journal-title":"J Pediatr"},{"key":"846_CR55","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s40120-023-00489-2","volume":"12","author":"D Weidlich","year":"2023","unstructured":"Weidlich D, Servais L, Kausar I, Howells R, Bischof M. Cost-effectiveness of newborn screening for spinal muscular atrophy in England. Neurol Ther. 2023;12:1205\u201320.","journal-title":"Neurol Ther"},{"key":"846_CR56","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jpeds.2020.07.033","volume":"227","author":"A Jalali","year":"2020","unstructured":"Jalali A, Rothwell E, Botkin JR, Anderson RA, Butterfield RJ, Nelson RE. Cost-effectiveness of nusinersen and universal newborn screening for spinal muscular atrophy. J Pediatr. 2020;227:274-80.e2.","journal-title":"J Pediatr"},{"key":"846_CR57","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jval.2022.06.010","volume":"25","author":"R Velikanova","year":"2022","unstructured":"Velikanova R, van der Schans S, Bischof M, van Olden RW, Postma M, Boersma C. Cost-effectiveness of newborn screening for spinal muscular Atrophy in The Netherlands. Value Health. 2022;25:1696\u2013704.","journal-title":"Value Health"},{"key":"846_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0283024","volume":"18","author":"R Tesorero","year":"2023","unstructured":"Tesorero R, Janda J, H\u00f6rster F, Feyh P, M\u00fctze U, Hauke J, et al. A high-throughput newborn screening approach for SCID, SMA, and SCD combining multiplex qPCR and tandem mass spectrometry. PLoS One. 2023;18:e0283024.","journal-title":"PLoS One"},{"key":"846_CR59","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clinbiochem.2017.10.016","volume":"52","author":"A Smon","year":"2018","unstructured":"Smon A, Repic Lampret B, Groselj U, Zerjav Tansek M, Kovac J, Perko D, et al. Next generation sequencing as a follow-up test in an expanded newborn screening programme. Clin Biochem. 2018;52:48\u201355.","journal-title":"Clin Biochem"},{"key":"846_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.662254","volume":"12","author":"ZI Remec","year":"2021","unstructured":"Remec ZI, Trebusak Podkrajsek K, Repic Lampret B, Kovac J, Groselj U, Tesovnik T, et al. Next-generation sequencing in newborn screening: a review of current state. Front Genet. 2021;12:662254.","journal-title":"Front Genet"},{"key":"846_CR61","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s12519-022-00670-x","volume":"19","author":"RL Yang","year":"2023","unstructured":"Yang RL, Qian GL, Wu DW, Miao JK, Yang X, Wu BQ, et al. A multicenter prospective study of next-generation sequencing-based newborn screening for monogenic genetic diseases in China. World J Pediatr. 2023;19:663\u201373.","journal-title":"World J Pediatr"},{"key":"846_CR62","doi-asserted-by":"publisher","first-page":"322","DOI":"10.5847\/wjem.j.1920-8642.2023.063","volume":"14","author":"B Deng","year":"2023","unstructured":"Deng B, Hua J, Zhou Y, Zhan D, Zhu L, Zhan Y, et al. Legionella pneumonia complicated with rhabdomyolysis and acute kidney injury diagnosed by metagenomic next-generation sequencing: a case report. World J Emerg Med. 2023;14:322\u20134.","journal-title":"World J Emerg Med"},{"key":"846_CR63","first-page":"802","volume":"4","author":"Z He","year":"2022","unstructured":"He Z, Xu T. China\u2019s actions to achieve universal health coverage for children. China CDC Wkly. 2022;4:802\u20136.","journal-title":"China CDC Wkly"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-024-00846-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-024-00846-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-024-00846-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T02:45:55Z","timestamp":1733885155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-024-00846-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":63,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["846"],"URL":"https:\/\/doi.org\/10.1007\/s12519-024-00846-7","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"25 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of the Ethics Committee in Children\u2019s Hospital, Zhejiang University School of Medicine (approval number 2021-IRB-036). Informed consent to infants in the study has been obtained from their parent or legal guardian.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}